Our pre-clinical development of proprietary drug candidates is advanced by project-specific relationships with clinicians and scientists from Australia’s leading medical research institutions and hospitals.

The Canthera Discovery translational research group develops, validates and performs target-specific functional bioassays, biomarker assays, in vivo models and imaging strategies for the evaluation of novel compounds

From bench to bedside – our expertise in cancer biology, translational research and clinical practice ensures that all our projects will have the best possible chance of transitioning seamlessly from preclinical to clinical development.